AzTrials
AzTrials

Supracondylar Humerus FractureFractureNCT04780308

Pediatric Type III Supracondylar Humeral Fracture

An observational study of Supracondylar Humerus Fracture and Pediatric Fractures, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to compare pin configuration effects on early secondary displacement in the surgical treatment of pediatric supracondylar humeral fractures (SCHF). Read more about this study

Who is it for?
Ages Up to 16 years
What is being tested?
Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
Type of treatment
Surgery or procedure
How many people
100 participants
Where
No sites listed yet
Study dates
1 Jan 2010to 20 Feb 2015
How long will I take part?
12 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients under 16 years.

Who may be able to join

  • Pediatric Gartland Type 3 supracondylar humeral fracture
  • Patients operated between 2010-2013
  • Patients under 16 years old

Who cannot join

  • Pathological fractures
  • Conservative treated supracondylar fractures
  • Less than the 1-year follow-up
  • Patients with incomplete postoperative follow-up
  • Patients older than 16 years
  • Pediatric Gartland Type 1 and 2 supracondylar humeral fracture

About this study

Official title: How Many K Wires do we Need in the Surgical Treatment of Pediatric Type III Supracondylar Humeral Fracture?

The purpose of this study was to compare pin configuration effects on early secondary displacement in the surgical treatment of pediatric supracondylar humeral fractures (SCHF).

Read the detailed description

The study consisted of 100 (68M, 32F) children who underwent surgery between 2010 and 2013 for Gartland Type 3 (SCHF). The patients divided into five groups according to the top in configurations (crossed 1 lateral 1 medial, crossed 2 lateral 1 medial, crossed 1 lateral 2 medial, 2 lateral divergent, and 3 lateral divergent). The average age at the time of injury was 7.34 (between 2 and 14 years). Bauman angle (BA), Humerocapital angle (HCA), Anterior humeral line (AHL), flexion range, extension range, and Carrying angle (CA) were compared at preoperative, postoperative 1st-day, postoperative last control, and non-operated side. The mean follow-up time 24,96±11,06 with a range of 12-54 months.

Being tested
Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
Keywords
pediatric, supracondylar humeral fracture, k wires, closed reduction, pin configuration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wiresProcedure or surgery

    The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

Study groups in NCT04780308
Study groupRoleWhat they receive
1 medial 1 lateral K-wirePediatric Gartland Type 3 supracondylar humeral fractures fixed by 1 medial 1 lateral K-wire
Receives: Procedure: Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
1 medial 2 lateral K-wirePediatric Gartland Type 3 supracondylar humeral fractures fixed by 1 medial 2 lateral K-wire
Receives: Procedure: Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
2 medial 1 lateral K-wirePediatric Gartland Type 3 supracondylar humeral fractures fixed by 2 medial 1 lateral K-wire
Receives: Procedure: Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
2 lateral K-wirePediatric Gartland Type 3 supracondylar humeral fractures fixed by 2 lateral K-wire
Receives: Procedure: Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires
3 lateral K-wirePediatric Gartland Type 3 supracondylar humeral fractures fixed by 3 lateral K-wire
Receives: Procedure: Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baumann Angle

    This angle is formed by the humeral axis and a straight line through the epiphyseal plate of the capitellum. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

    Measured: postoperative 1. day, 1. month and 12. month

  2. Anterior Humeral Line

    A line drawn down the anterior surface of the humerus should intersect the middle third of the capitellum. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

    Measured: postoperative 1. day, 1. month and 12. month

  3. Humero-Capital Angle

    On lateral X-ray angle between capitellum and humeral shaft. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

    Measured: postoperative 1. day, 1. month and 12. month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2021
  2. Study start1 Jan 2010
  3. Primary completion31 Dec 2013
  4. Study completion20 Feb 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
100 participants (actual)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04780308
Sponsor's protocol ID
2014/18/05
Acronym
Fracture
Status last verified
Feb 2021
First submitted
7 Feb 2021
Last updated
3 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Supracondylar Humerus Fracture and Pediatric Fractures, run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baumann Angle (time frame: postoperative 1. day, 1. month and 12. month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in